UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549

                              FORM 10-QSB

[X]    QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

       For the quarterly period ended September 30, 2007

[ ]    TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

    For the transition period from ___________ to ____________

                    Commission file number 000-49768

                           DENTALSERV.COM
   -----------------------------------------------------------------
   (Exact name of small business issuer as specified in its charter)

           Nevada                                   91-2015980
 ---------------------------             ---------------------------------
(State or other jurisdiction             (IRS employer identification no.)
      of incorporation)

                   20 West 55th Street, 5th Floor
                      New York, New York 10010
              ----------------------------------------
              (Address of principal executive offices)

              Issuer's telephone number: (212) 849-8248

Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the
past 90 days.

                  Yes [X]                   No [ ]

Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act).

                  Yes [X]                   No [ ]

                APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each the issuer's classes of
common equity, as of the latest practicable date: 5,612,750 shares of
Common Stock, par value $.001 per share, outstanding as of October 31,
2007.

Transitional Small Business Disclosure Format (Check One):

                  Yes [ ]                   No [X]

<PAGE>

                          DENTALSERV.COM

                            Form 10-QSB

             For the Quarter Ended September 30, 2007

                          TABLE OF CONTENTS

                                                                 Page
                                                                 ----
PART I - FINANCIAL INFORMATION

Item 1.  Financial Statements (Unaudited)
         Condensed Balance Sheet................................   1
         Condensed Statements of Operations.....................   2
         Condensed Statement of Stockholders' Deficit...........   3
         Condensed Statements of Cash Flows.....................   4
         Notes to Condensed Financial Statements................   5

Item 2.  Management's Discussion & Analysis or Plan
         of Operation...........................................   7

Item 3.  Controls and Procedures................................   9

PART II - OTHER INFORMATION

Item 1.  Legal Proceedings......................................   10

Item 2.  Unregistered Sales of Equity Securities and
         Use of Proceeds........................................   10

Item 3.  Defaults Upon Senior Securities........................   10

Item 4.  Submission of Matters to a Vote of Security Holders....   10

Item 5   Other Information......................................   10

Item 6.  Exhibits...............................................   10

SIGNATURES......................................................   11
























<PAGE>

                           DENTALSERV.COM
                    (A Development Stage Company)
                       CONDENSED BALANCE SHEET
                         SEPTEMBER 30, 2007
                             (Unaudited)

ASSETS

Current assets:
  Cash                                                    $   12,769
                                                          ----------
Total assets                                              $   12,769
                                                          ==========

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:
  Accounts payable and accrued expenses                   $   22,838
  Advance payable - stockholder                               45,000
                                                          ----------
Total current liabilities                                     67,838
                                                          ----------

Stockholders' deficit:
  Common stock, $0.001 par value;
    100,000,000 shares authorized,
    5,605,750 shares issued and outstanding                    5,606
        Additional paid-in capital                            45,178
    Deficit accumulated during the development stage        (105,853)
                                                          ----------
Total stockholders' deficit                                  (55,069)
                                                          ----------
Total liabilities and stockholders' deficit               $   12,769
                                                          ==========























See Notes to Financial Statements.



                                 -1-
<PAGE>


                           DENTALSERV.COM
                    (A Development Stage Company)
                 CONDENSED STATEMENTS OF OPERATIONS
                             (Unaudited)

<TABLE>
<CAPTION>
                                                                                                             Cumulative Period
                                                                                                          from December 15, 1999
                                                                                                                 (Inception)
                                       Three Months Ended September 30,  Nine Months Ended September 30,      to September 30,
                                              2007          2006              2007          2006                     2007
                                       ---------------   --------------  -------------   ---------------  ----------------------
<S>                                    <C>               <C>             <C>             <C>              <C>
Operating expenses:
   General and administrative                  33,312         1,230            78,381         4,140                 105,853
                                           ----------    ----------        ----------    ----------             -----------

Total operating expenses                       33,312         1,230            78,381         4,140                 105,853
                                           ----------    ----------        ----------    ----------             -----------


Loss from operations before income taxes      (33,312)       (1,230)          (78,381)       (4,140)               (105,853)

Income taxes                                        -             -                 -             -                       -
                                           ----------    ----------        ----------    ----------             -----------
Net loss                                   $  (33,312)   $   (1,230)       $  (78,381)   $   (4,140)            $  (105,853)
                                           ==========    ==========        ==========    ==========             ===========

Basic and diluted net loss per share       $    (0.01)   $    (0.00)       $    (0.01)   $    (0.00)
                                           ==========    ==========        ==========    ==========

Weighted average number of shares used
  in computing basic and fully diluted
  loss per share amounts                    5,598,359     5,573,500         5,586,460     5,573,500
</TABLE>


















See Notes to Financial Statements.



                                 -2-
<PAGE>


                           DENTALSERV.COM
                    (A Development Stage Company)
     CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT

<TABLE>
<CAPTION>
                                                                     Deficit
                                                                  Accumulated
                                                     Additional      During         Total
                                  Common Stock        Paid-In     Development   Stockholders'
                                Shares      Amount    Capital        Stage         Equity
                              ----------   --------  -----------  -----------   -------------
<S>                           <C>          <C>       <C>          <C>           <C>

Sale of shares for cash        4,950,000   $  4,950  $   (3,150)  $         -   $       1,800
                              ----------   --------  ----------   -----------     -----------


Balance, December 31, 1999     4,950,000      4,950      (3,150)            -           1,800

Net loss                               -          -           -        (2,419)         (2,419)
                              ----------   --------  ----------   -----------     -----------

Balance, December 31, 2000     4,950,000      4,950      (3,150)       (2,419)           (619)

Net loss                               -          -           -        (2,419)         (2,419)
                              ----------   --------  ----------   -----------     -----------

Balance, December 31, 2001     4,950,000      4,950      (3,150)       (4,838)         (3,038)

Conversion of debt to capital          -          -       3,000             -           3,000

Net loss                               -          -           -        (2,001)         (2,001)
                              ----------   --------  ----------   -----------     -----------

Balance, December 31, 2002     4,950,000      4,950        (150)       (6,839)         (2,039)

Sale of shares for cash          574,500        574      11,696             -          12,270

Net loss                               -          -           -        (2,487)         (2,487)
                              ----------   --------  ----------   -----------     -----------

Balance, December 31, 2003     5,524,500      5,524      11,546        (9,326)          7,744

Net loss                               -          -           -        (5,845)         (5,845)
                              ----------   --------  ----------   -----------     -----------

Balance, December 31, 2004     5,524,500      5,524      11,546       (15,171)          1,899

Shares issued for software        50,000         50       7,450             -           7,500

Net loss                               -          -           -        (5,942)         (5,942)
                              ----------   --------  ----------   -----------     -----------

Balance, December 31, 2005     5,574,500      5,574      18,996       (21,113)          3,457

Conversion of net debt to
  capital                              -          -       2,902             -           2,902

Net loss                               -          -           -        (6,359)         (6,359)
                              ----------   --------  ----------   -----------     -----------

Balance, December 31, 2006     5,574,500      5,574      21,898       (27,472)              -

Issuance of common stock for
  services (Unaudited)            31,250         32      23,280                        23,312

Net loss (Unaudited)                   -          -           -       (78,381)        (78,381)
                              ----------   --------  ----------   -----------     -----------
Balance, September 30, 2007
  (Unaudited)                  5,605,750   $  5,606  $   45,178   $  (105,853)    $   (55,069)
                              ==========   ========  ==========   ===========     ===========
</TABLE>




See Notes to Financial Statements.



                                 -3-
<PAGE>


                           DENTALSERV.COM
                    (A Development Stage Company)
                   CONDENSED STATEMENTS OF CASH FLOWS
                            (Unaudited)
<TABLE>
<CAPTION>
                                                                                      Cumulative Period
                                                                                      from December 15, 1999
                                                                                          (Inception) to
                                                    Nine Months Ended September 30,        September 30,
                                                         2007               2006                2007
                                                    ------------        -----------   ----------------------
<S>                                                 <C>                 <C>           <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss                                            $   (78,381)        $   (4,140)        $   (105,853)
Adjustments to reconcile net loss to net
  cash used in operating activities:
   Stock based compensation                              23,312                  -               23,312
   Change in operating assets and liabilities:
   Accounts payable and accrued expenses                 22,838                  -               22,838
                                                    -----------         ----------         ------------

Net cash used in operating activities                   (32,231)            (4,140)             (59,703)
                                                    -----------         ----------         ------------

CASH FLOWS FROM FINANCING ACTIVITIES:
Sale of common stock                                          -                  -               17,071
Advances from stockholder                                45,000              4,271               55,421
Distribution to stockholder                                   -                  -                  (20)
                                                    -----------         ----------         ------------

Net cash provided by financing activities                45,000              4,271               72,472
                                                    -----------         ----------         ------------

Net increase cash                                        12,769                131               12,769

Cash and cash equivalents, beginning of period                -                (42)                   -
                                                    -----------         ----------         ------------

Cash and cash equivalents, end of period            $    12,769         $       89         $     12,769
                                                    ===========         ==========         ============


Supplemental disclosure of cash flow information:

   Cash paid for interest                           $         -         $        -         $          -
                                                    ===========         ==========         ============


</TABLE>




See Notes to Financial Statements.



                                 -4-
<PAGE>

                           DENTALSERV.COM

              NOTES TO CONDENSED FINANCIAL STATEMENTS
                      SEPTEMBER 30, 2007 AND 2006
                             (Unaudited)

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Nature of Operations

Dentalserv.com (we", "us", "the Company", "our" or "Dentalserv") was
formed under the laws of the State of Delaware on December 15, 1999.
We had planned to develop our dental software package in 2000-2003 but
our principal stockholder became involved in other activities.
Attempts to develop the package in proved unacceptable and the project
was abandoned in late 2006.

On December 15, 2006, our principal stockholder sold 5,016,150 shares
(90%) of our common stock to a group of investors for $650,000 cash.
The sale was accompanied by the resignation and replacement of our
officers and directors. We are now considering alternatives for future
operations. We are a development stage company, as defined by
Statement of Financial Accounting Standards (SFAS") No. 7.

Basis of Presentation

The accompanying unaudited condensed financial statements as of
September 30, 2007 and for the nine and three month periods ended
September 30, 2007 and 2006 and from inception (December 15, 1999) to
September 30, 2007 have been prepared by Dentalserv pursuant to the
rules and regulations of the Securities and Exchange Commission,
including Form 10-QSB and Regulation S-B. The information furnished
herein reflects all adjustments (consisting of normal recurring
accruals and adjustments), which are, in the opinion of management,
necessary to fairly present the operating results for the respective
periods. Certain information and footnote disclosures normally present
in annual financial statements prepared in accordance with accounting
principles generally accepted in the United States of America have
been omitted pursuant to such rules and regulations. The company
believes that the disclosures provided are adequate to make the
information presented not misleading. These financial statements
should be read in conjunction with the audited financial statements
and explanatory notes for the year ended December 31, 2006 as
disclosed in the company's 10-KSB for that year as filed with the SEC,
as it may be amended.

The results of the nine months ended September 30, 2007 are not
necessarily indicative of the results to be expected for the pending
full year ending December 31, 2007.

Use of Estimates

The preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the amounts
reported in the condensed financial statements and accompanying
disclosures. Although these estimates are based on management's best
knowledge of current events and actions the Company may undertake in
the future, actual results may differ from those estimates.

Going Concern

The financial statements have been prepared on a going concern basis,
and do not reflect any adjustments related to the uncertainty
surrounding our recurring losses or accumulated deficit.

We have incurred continuing losses since inception, with no revenue
during that period and currently have no current source of revenue.
These factors raise substantial doubt about our ability to continue as
a going concern.

We are pursuing an acquisition strategy, whereby we seek to acquire
businesses with a history of operating revenues in markets that
provide room for growth. We recently engaged in identifying,
investigating and acquiring a company that will likely enhance revenue
and increase shareholder value. In the event that our limited
financial resources prove to be insufficient to implement our
acquisition strategy, we will be required to seek additional
financing, through equity.

Loss per Share

We use SFAS No. 128, "Earnings Per Share" for calculating the basic
and diluted loss per share. We compute basic loss per share by
dividing net loss and net loss attributable to common shareholders by
the weighted average number of common shares outstanding. Diluted loss
per share is computed similar to basic loss per share except that the
denominator is increased to include the number of additional common
shares that would have been outstanding if the potential shares had
been issued and if the additional shares were dilutive. Common
equivalent shares are excluded from the computation of net loss per
share if their effect is anti-dilutive. There were no common share
equivalents at September 30, 2007 or 2006.


                                 -5-
<PAGE>

Recent Accounting Pronouncements

In February 2007, the FASB issued SFAS No. 159, "The Fair Value Option
for Financial Assets and Financial Liabilities - Including an
Amendment of FASB Statement No. 115." This statement permits entities
to choose to measure many financial instruments and certain other
items at fair value. Most of the provisions of SFAS No. 159 apply only
to entities that elect the fair value option. However, the amendment
to SFAS No. 115, "Accounting for Certain Investments in Debt and
Equity Securities," applies to all entities with available-for-sale
and trading securities. SFAS No. 159 is effective as of the beginning
of an entity's first fiscal year that begins after November 15, 2007.
Early adoption is permitted as of the beginning of a fiscal year that
begins on or before November 15, 2007, provided the entity also elects
to apply the provision of SFAS No. 157, "Fair Value Measurements." The
adoption of this statement is not expected to have a material effect
on the Company's financial statements.

NOTE 2 - STOCKHOLDERS' EQUITY

During March and August, 2007, we issued an aggregate of 31,250 shares
of common stock, valued at $23,312, for services.

NOTE 3 - LOANS PAYABLE - SHAREHOLDERS

Advance payable to stockholder consists of non-interest bearing
working capital advances, due on demand.

NOTE 4 -PENDING TRANSACTIONS

Our Board of Directors and shareholders holding the necessary number
of votes have approved an amendment (the "Articles of Amendment") of
our Articles of Incorporation to (a) change our name to Medpro Safety
Products, Inc. in connection with the merger of that company with and
into Dentalserv.com and (b) (i) effect a 1 for 4 reverse split of our
common stock (the "Reverse Split") and (ii) effect a change in our
total authorized capital stock (the "Capital Change") to 100,000,000
shares, of which 90,000,000 will remain classified as common stock,
par value $.001 per share, and 10,000,000 shares will be classified as
preferred stock, par value $.001 per share, issuable in series with
such powers, designations, preferences and relative, participating,
optional or other special rights, and qualifications, limitations or
restrictions thereof, as the Board may fix from time to time by
resolution or resolutions.

The effect of the Reverse Split will cause each 4 outstanding shares
of common stock to automatically change into 1 share of common stock,
effectively increasing the number of authorized shares of our common
stock available for issuance.

Our board of directors approved the Reverse Split for the following
reasons:

(a) it believes that this action may lead to a higher per share stock
price and may help generate investor interest in the Company;

(b) it believes this action may help attract additional investment in
the Company; and

(c) it believes this action is the next logical step in the process of
restructuring the Company to align the Company's outstanding shares of
capital stock with the Company's anticipated post-Reverse Merger
financial condition and operations to provide an opportunity for
potential realization of shareholder value, which would otherwise be
subject to the dilutive effects of the Company's capital structure.

The net number of shares of authorized, unissued shares of common
stock that will be available as a result of the Reverse Split and
after the Capital Change, if and when issued, will have the same
rights and privileges as the shares of common stock presently issued
and outstanding. The Articles of Amendment and the consequent decrease
in the number of shares of authorized common stock will not alter the
current number of issued shares except to the extent of the Reverse
Split. The relative rights and limitations of the shares of our common
stock will remain unchanged under the Articles of Amendment.

The purpose of changing our corporate name is to reflect our
acquisition, prior to December 31, 2007, of all of the outstanding
shares of capital stock of Medpro Safety Products, Inc. ("MedPro").
All of the outstanding shares of capital stock of MedPro will be
acquired in a reverse merger of MedPro with and into the Company (the
"Reverse Merger") pursuant to an agreement and plan of merger by and
between the Company, MedPro and the holders of all of the outstanding
capital stock of MedPro (the "Amended and Restated Agreement and Plan
of Merger"). As a result of the Reverse Merger, the business of MedPro
will be conducted by the Company and the management and Board of
MedPro will become the Company's management and Board of Directors. It
is contemplated that following completion of the Reverse Merger, for
the foreseeable future the business of MedPro will constitute the
principal business of the Company under its new name, Medpro Safety
Products, Inc.

As of September 30, 2007, a total of 5,605,750 (pre-reverse split); or
1,401,438 (post-reverse split) shares of the Company's currently
authorized 100,000,000 shares of common stock were issued and
outstanding. After effectiveness of the Articles of Amendment, our
authorized common stock will be reduced to 90,000,000 shares, of which
approximately 11,878,628 shares of unissued common stock will be
reserved for issuance in connection with the Reverse Merger
transaction; and 35,556,416 shares of unissued common stock will be
reserved for issuance upon the exercise of all of the anticipated
rights to receive shares of common stock issued in our Private
Placement of up to 6,668,230 Units comprised of newly authorized
Series A Convertible Preferred Stock and Common Stock Purchase
Warrants. Accordingly, absent a further capital change, not now


                                 -6-
<PAGE>

contemplated, the Company will have approximately 41,168,956 shares of
authorized, unreserved and unissued Common Stock available to be
issued in the future. The share numbers specified in this paragraph,
unless otherwise noted, give effect to the Reverse Split.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

Statements included in this and future filings by us with the
Securities and Exchange Commission, in our press releases and in oral
statements made with the approval of an authorized executive officer
which are not historical or current facts are "forward- looking
statements" and are subject to certain risks and uncertainties that
could cause actual results to differ materially from historical
earnings and those presently anticipated or projected. You are
cautioned not to place undue reliance on any such forward-looking
statements, which speak only as of the date made. The following
important factors, among others, in some cases have affected and in
the future could affect our actual results and could cause our actual
financial performance to differ materially from that expressed in any
forward-looking statement: (i) the extremely competitive conditions
that currently exist in the market for companies similar to us and
(ii) lack of resources to maintain our good standing status and
requisite filings with the Securities and Exchange Commission. The
foregoing list should not be construed as exhaustive and we disclaim
any obligation subsequently to revise any forward-looking statements
to reflect events or circumstances after the date of such statements
or to reflect the occurrence of anticipated or unanticipated events.
The following discussion should be read in conjunction with our
financial statements and their explanatory notes included as part of
this quarterly report.

Overview

As of December 15, 2006, our board of directors determined that the
implementation of the Company's business plan prior to the change in
control was no longer financially feasible. We are now pursuing an
acquisition strategy, whereby we seek to acquire undervalued
businesses with a history of operating revenues in markets that
provide room for growth ("Acquisition Strategy"). We are engaged in
identifying, investigating and, if investigation warrants, acquiring
companies that will enhance our revenues and increase shareholder
value (please refer to "Pending Transactions" below).

Our Acquisition Strategy is focused on pursuing a strategy of growth
by acquiring undervalued businesses with a history of operating
revenues. We utilize several criteria to evaluate prospective
acquisitions including whether the business to be acquired (1) is an
established business with viable services or products, (2) has an
experienced and qualified management team, (3) has room for growth
and/or expansion into other markets, (4) is accretive to earnings, (5)
offers the opportunity to achieve and/or enhance profitability, and
(6) increases shareholder value. We are considered to be in the
development stage as defined by Statement of Financial Accounting
Standards No. 7, "Accounting and Reporting by Development Stage
Enterprises".

Critical Accounting Policies

Our condensed financial statements have been prepared in accordance
with accounting principles generally accepted in the United States of
America. The preparation of these financial statements requires
management to make estimates and assumptions that affect the reported
amounts of assets, liabilities, revenues and expenses. Note 1 of the
Notes to Condensed Financial Statements describes the significant
accounting policies used in the preparation of the condensed financial
statements. Certain of these significant accounting policies are
considered to be critical accounting policies, as defined below. We do
not believe that there have been significant changes to our accounting
policies during the nine months ended September 30, 2007, as compared
to those policies disclosed in the December 31, 2006 financial
statements filed in our Annual Report on Form 10-KSB with the SEC on
March 30, 2007.

A critical accounting policy is defined as one that is both material
to the presentation of our financial statements and requires
management to make difficult, subjective or complex judgments that
could have a material effect on our financial condition and results of
operations. Specifically, critical accounting estimates have the
following attributes: 1) we are required to make assumptions about
matters that are highly uncertain at the time of the estimate; and 2)
different estimates we could reasonably have used, or changes in the
estimate that are reasonably likely to occur, would have a material
effect on our financial condition or results of operations.

Estimates and assumptions about future events and their effects cannot
be determined with certainty. We base our estimates on historical
experience and on various other assumptions believed to be applicable
and reasonable under the circumstances. These estimates may change as
new events occur, as additional information is obtained and as our
operating environment changes. These changes have historically been
minor and have been included in the condensed financial statements as
soon as they became known. Based on a critical assessment of our
accounting policies and the underlying judgments and uncertainties
affecting the application of those policies, management believes that
our condensed financial statements are fairly stated in accordance
with accounting principles generally accepted in the United States,
and present a meaningful presentation of our financial condition and
results of operations. We believe the following critical accounting
policies reflect our more significant estimates and assumptions used
in the preparation of our condensed financial statements:

Use of Estimates - These financial statements have been prepared in
accordance with accounting principles generally accepted in the United
States of America and, accordingly, require management to make
estimates and assumptions that affect the reported amounts of assets
and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period.
Specifically, our management has estimated our net operating loss for
tax purposes. Actual results could differ from those estimates.

                                 -7-
<PAGE>

Cash and Equivalents - We maintain our cash in bank deposit accounts,
which at times, may exceed federally insured limits. We have not
experienced any losses in such account.

Going Concern

We are currently in the process of implementing our business plan. At
present, we have sufficient capital on hand to fund our operations
only through November of 2007. There can be no assurance that upon
implementing our new business plan, we will be successful or that we
will start producing sufficient revenues to maintain our operations.
The foregoing matters raise substantial doubt about our ability to
continue as a going concern.

Results of Operations

General and Administrative Expenses

General and administrative expenses were $33,312 for the three months
ended September 30, 2007, as compared to $1,230 for the three months
ended September 30, 2006. The current period expenses were comprised
primarily of compensation expense of $5,925 and professional fees of
$23,953. General and administrative expenses were $78,381 for the nine
months ended September 30, 2007, as compared to $4,140 for the nine
months ended September 30, 2006. The current period expenses were
comprised primarily of compensation expense of $38,175 and
professional fees of $35,575. As of December 15, 2006, our board of
directors determined that the implementation of the Company's business
plan prior to the change in control was no longer financially
feasible. We are now pursuing an acquisition strategy, whereby we will
seek to acquire undervalued businesses with a history of operating
revenues in markets that provide room for growth.

Plan of Operation

We are pursuing an Acquisition Strategy, whereby we seek to acquire
undervalued businesses with a history of operating revenues in markets
that provide room for growth. We are primarily engaged in identifying,
investigating and, if investigation warrants, acquiring companies that
will enhance our revenues and increase shareholder value. Our
Acquisition Strategy is focused on pursuing a strategy of growth by
acquiring undervalued businesses with a history of operating revenues.
We will utilize several criteria to evaluate prospective acquisitions
including whether the business to be acquired (1) is an established
business with viable services or products, (2) has an experienced and
qualified management team, (3) has room for growth and/or expansion
into other markets, (4) is accretive to earnings, (5) offers the
opportunity to achieve and/or enhance profitability, and (6) increases
shareholder value.

We recently engaged in identifying, investigating and acquiring a
company that will likely enhance revenue and increase shareholder
value (please refer to "Pending Transactions" below).

Liquidity and Capital Resources

As of September 30, 2007 we had cash of $12,169 but a deficit in
working capital of $55,069. During the nine month period ended
September 30, 2007, we received advances from our principal
stockholder in the aggregate amount of $45,000 for working capital
purposes. An additional $15,000 advance was received in October. Our
cash balance is not sufficient to maintain our business and to finance
acquisitions. Accordingly, before December 2007, management will need
to raise additional funds in order to continue operating. There can be
no assurances that we will be able to obtain additional funds if and
when needed.

Pending Transactions

Our Board of Directors and shareholders holding the necessary number
of votes have approved an amendment (the "Articles of Amendment") of
our Articles of Incorporation to (a) change our name to Medpro Safety
Products, Inc. in connection with the merger of that company with and
into Dentalserv.com and (b) (i) effect a 1 for 4 reverse split of our
common stock (the "Reverse Split") and (ii) effect a change in our
total authorized capital stock (the "Capital Change") to 100,000,000
shares, of which 90,000,000 will remain classified as common stock,
par value $.001 per share, and 10,000,000 shares will be classified as
preferred stock, par value $.001 per share, issuable in series with
such powers, designations, preferences and relative, participating,
optional or other special rights, and qualifications, limitations or
restrictions thereof, as the Board may fix from time to time by
resolution or resolutions.

The effect of the Reverse Split will cause each 4 outstanding shares
of common stock to automatically change into 1 share of common stock,
effectively increasing the number of authorized shares of our common
stock available for issuance.

Our board of directors approved the Reverse Split for the following
reasons:

(a) it believes that this action may lead to a higher per share stock
price and may help generate investor interest in the Company;

(b) it believes this action may help attract additional investment in
the Company; and

                                 -8-
<PAGE>

(c) it believes this action is the next logical step in the process of
restructuring the Company to align the Company's outstanding shares of
capital stock with the Company's anticipated post-Reverse Merger
financial condition and operations to provide an opportunity for
potential realization of shareholder value, which would otherwise be
subject to the dilutive effects of the Company's capital structure.

The net number of shares of authorized, unissued shares of common
stock that will be available as a result of the Reverse Split and
after the Capital Change, if and when issued, will have the same
rights and privileges as the shares of common stock presently issued
and outstanding. The Articles of Amendment and the consequent decrease
in the number of shares of authorized common stock will not alter the
current number of issued shares except to the extent of the Reverse
Split. The relative rights and limitations of the shares of our common
stock will remain unchanged under the Articles of Amendment.

The purpose of changing our corporate name is to reflect our
acquisition, prior to December 31, 2007, of all of the outstanding
shares of capital stock of Medpro Safety Products, Inc. ("MedPro").
All of the outstanding shares of capital stock of MedPro will be
acquired in a reverse merger of MedPro with and into the Company (the
"Reverse Merger") pursuant to an agreement and plan of merger by and
between the Company, MedPro and the holders of all of the outstanding
capital stock of MedPro (the "Agreement and Plan of Merger"). As a
result of the Reverse Merger, the business of MedPro will be conducted
by the Company and the management and Board of MedPro will become the
Company's management and Board of Directors. It is contemplated that
following completion of the Reverse Merger, for the foreseeable future
the business of MedPro will constitute the principal business of the
Company under its new name, Medpro Safety Products, Inc.

As of September 30, 2007, a total of 5,605,750 (pre-reverse split); or
1,401,438 (post-reverse split) shares of the Company's currently
authorized 100,000,000 shares of common stock were issued and
outstanding. After effectiveness of the Articles of Amendment, our
authorized common stock will be reduced to 90,000,000 shares, of which
approximately 11,878,628 shares of unissued common stock will be
reserved for issuance in connection with the Reverse Merger
transaction; and 35,556,416 shares of unissued common stock will be
reserved for issuance upon the exercise of all of the anticipated
rights to receive shares of common stock issued in our Private
Placement of up to 6,668,230 Units comprised of newly authorized
Series A Convertible Preferred Stock and Common Stock Purchase
Warrants. Accordingly, absent a further capital change, not now
contemplated, the Company will have approximately 41,168,956 shares of
authorized, unreserved and unissued Common Stock available to be
issued in the future. The share numbers specified in this paragraph,
unless otherwise noted, give effect to the Reverse Split.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet guarantees, interest rate swap
transactions or foreign currency contracts. We do not engage in
trading activities involving non-exchange traded contracts.

ITEM 3. CONTROLS AND PROCEDURES

We maintain disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) of the Exchange Act) that are designed to be
effective in providing reasonable assurance that information required
to be disclosed in our reports under the Securities Exchange Act of
1934 is recorded, processed, summarized and reported within the time
periods specified in the rules and forms of the SEC, and that such
information is accumulated and communicated to our management to allow
timely decisions regarding required disclosure.

In designing and evaluating disclosure controls and procedures,
management recognizes that any controls and procedures, no matter how
well designed and operated, can provide only reasonable, not absolute
assurance of achieving the desired objectives. Also, the design of a
control system must reflect the fact that there are resource
constraints and the benefits of controls must be considered relative
to their costs. Because of the inherent limitations in all control
systems, no evaluation of controls can provide absolute assurance that
all control issues and instances of fraud, if any, have been detected.
These inherent limitations include the realities that judgments in
decision-making can be faulty and that breakdowns can occur because of
simple error or mistake. The design of any system of controls is
based, in part, upon certain assumptions about the likelihood of
future events and there can be no assurance that any design will
succeed in achieving its stated goals under all potential future
conditions.

The Company, with the participation of its management, including its
Chief Executive Officer and Chief Financial Officer, carried out an
evaluation of the effectiveness of the design and operation of its
disclosure controls and procedures (as defined in Rules 13a-15 and
15d-15 under the Securities Exchange Act of 1934) as of the end of the
period covered by this report. Based upon that evaluation and as of
the end of the period covered by this report, the Company's Chief
Executive Officer and Chief Financial Officer concluded that the
Company's disclosure controls and procedures are effective in timely
alerting them to information required to be disclosed in its reports
that the Company files or submits to the Securities and Exchange
Commission under the Securities Exchange Act of 1934. There have been
no changes in the Company's internal controls over financial reporting
that occurred during the period covered by this report that have
materially affected, or are reasonably likely to materially affect,
the Company's internal controls over financial reporting.

ITEM 3A. (T) CONTROLS AND PROCEDURES

This item is not applicable.


                                 -9-
<PAGE>

                      PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

This item is not applicable.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

We plan to undertake and close a private placement of our newly
authorized preferred stock in units with various common stock purchase
warrants, for gross proceede of $13,000,000. The units will be
purchased primarily by our controlling shareholder, Vision Opportunity
Master Fund. The private placement is to be coincident with and
conditioned upon closing of the pending reverse merger transaction and
the net proceeds of the sale will be used for corporate purposes by
the combined Company.


ITEM 3. DEFAULTS UPON SENIOR SECURITIES

This item is not applicable.


ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

This item is not applicable.


ITEM 5. OTHER INFORMATION

This item is not applicable.


ITEM 6. EXHIBITS

Exhibits

Exhibit Number     Description of Exhibit
--------------     ----------------------

    3.1            Articles of Incorporation as Amended (incorporated
                   by reference from our Form 10-SB Registration
                   Statement, filed July 21, 2006)

    3.2            Articles of Amendment (incorporated by reference from
                   our Form 10-SB, filed July 21, 2006)

    3.3            Bylaws (incorporated by reference from our Form 10-SB
                   Registration Statement, filed July 21, 2006)

    10.1           Stock Purchase Agreement (incorporated by reference to
                   our Form 8-K filed on December 19, 2006)

    10.2           Amended and Restated Agreement and Plan of Merger dated
                   November 7, 2007.

    31.1           Certification of Principal Executive Officer pursuant
                   to Section 302 of the Sarbanes-Oxley Act of 2002

    31.2           Certification of Principal Financial Officer pursuant
                   to Section 302 of the Sarbanes-Oxley Act of 2002

    32.1           Certification of Principal Executive Officer pursuant
                   to 18 U.S.C. Section 1350, as adopted pursuant to
                   Section 906 of the Sarbanes-Oxley Act of 2002.

    32.2           Certification of Principal Financial Officer pursuant
                   to 18 U.S.C. Section 1350, as adopted pursuant to
                   Section 906 of the Sarbanes-Oxley Act of 2002.

Reports on Form 8-K

A Current Report on Form 8-K/A was filed during the Quarter ended
September 30, 2007, on September 10, 2007 reporting the pending
Reverse Merger transaction, the 1 for 4 reverse split of our common
stock and various other corporate restructuring


                                -10-
<PAGE>


                              SIGNATURES

In accordance with the requirements of the Exchange Act, the
registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                  DENTALSERV.COM
                                  (Registrant)

                                  By: /s/ Lawrence Chimerine
                                     -------------------------------
                                  Name: Lawrence Chimerine
                                  Title: President and Chief
                                         Executive Officer

                                  Date: November 13, 2007


                                  By: /s/ Robert Scherne
                                     ------------------------------
                                  Name: Robert Scherne
                                  Title: Chief Financial Officer

                                  Date: November 13, 2007



























                                 -11-
<PAGE>